Go Pro
→ Barricks gold output fell from 2 million ounces to 719000 (From Golden Portfolio) (Ad)tc pixel Free EWTX Stock Alerts

Edgewise Therapeutics (EWTX) Earnings Date, Estimates & Call Transcripts

Edgewise Therapeutics logo
$43.69 +0.51 (+1.18%)
As of 02:33 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Edgewise Therapeutics Earnings Summary

Edgewise Therapeutics issued Q2 2026 earnings on August 6, 2026, reporting an EPS of -$0.53, which missed analysts' consensus estimates of -$0.47 by $0.06. With a trailing EPS of -$1.85, Edgewise Therapeutics' earnings are expected to grow next year, from ($2.09) to ($1.75) per share.

Latest Q2
Earnings Date
Aug. 6Estimated
Consensus EPS
(Aug. 6)
-$0.47
Actual EPS
(Aug. 6)
-$0.53 Missed By -$0.06

Q2 2026 Earnings Resources

Powered by Quartr
Get Edgewise Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Edgewise Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

EWTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Edgewise Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$0.52-$0.43-$0.48
Q2 20262-$0.55-$0.47-$0.51
Q3 20262-$0.58-$0.53-$0.56
Q4 20262-$0.60-$0.55-$0.58

Edgewise Therapeutics Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026-$0.4677-$0.53 -$0.0623-$0.53--
5/7/2026Q1 2026-$0.50-$0.46+$0.04-$0.46--
2/26/2026Q4 2025-$0.43-$0.47 -$0.04-$0.47--
11/6/2025Q3 2025-$0.40-$0.39+$0.01-$0.39--
8/7/2025Q2 2025-$0.42-$0.34+$0.08-$0.34--
5/8/2025Q1 2025-$0.45-$0.43+$0.02-$0.43--
3/3/2025Q4 2024-$0.39-$0.42 -$0.03-$0.42--
11/7/2024Q3 2024-$0.37-$0.36+$0.01-$0.36--

Edgewise Therapeutics Earnings - Frequently Asked Questions

Edgewise Therapeutics (NASDAQ:EWTX) last announced its quarterly earning data on Thursday, August 6, 2026. Learn more on EWTX's earnings history.

In the previous quarter, Edgewise Therapeutics (NASDAQ:EWTX) missed the analysts' consensus estimate of ($0.47) by $0.06 with a reported earnings per share (EPS) of ($0.53). Learn more on analysts' earnings estimate vs. EWTX's actual earnings.

Edgewise Therapeutics (NASDAQ:EWTX) has a recorded net income of -$167.79 million. EWTX has generated -$1.85 earnings per share over the last four quarters.

Edgewise Therapeutics' earnings are expected to grow from ($2.09) per share to ($1.75) per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:EWTX is sourced from Fiscal.ai, with the most recent quarter reported on 8/6/2026. New results are added as companies report their earnings.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
Why I'm sending this one to my own family
Behind the Markets editor Kelly Maguire says she has never sent an email quite like this one. A sealed congres...
Behind the Markets | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
Ray Dalio: Buy Gold. Get Paid.
Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...
Investors Alley | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Why November 27 Is Quickly Becoming America's Most Important Financial Date in Decades
An estimated $10 trillion could move through a little known government initiative, according to analyst Joel L...
Altimetry | Sponsoredtc pixel
Leading AI Insider Issues Urgent Market Warning
A leading AI pioneer has spent $17 million on AI research and tools since 2022, building a platform now used b...
TradeSmith | Sponsoredtc pixel